Share the post "Alkem Laboratories announced Financial Results Q1 2024"
Highlights
- The presented financial data is Standalone to provide a comprehensive overview of the company performance.
- Sales over the Year and quarter: The company experienced a substantial growth of 10.96 % in the past year, substantial increase in net sales/revenue by 5.7 %.
- Income over the Year and quarter: There has been either a marginal increase or a decline in other income over the past year which is 63.99 %. Marginal increase in other income during this quarter, up by 48.87%.
- Profit over the Year and quarter: Significant improvement in profitability for Alkem Laboratories Limited. Notable increase of 114.87 % in net profit Year to Year, Alkem Laboratories Limited’s profitability increased by 79.48 % in this quarter.
- EPS over the Year and quarter: EPS increased by 114.89 % Year to Year. EPS increased by 79.47 % in previous quarter. Positive impact on shareholders.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 2253.17 Cr | Rs. 2365.37 Cr | Rs. 2500.1 Cr | + 5.7 % | + 10.96 % |
Expenses | Rs. 1919.42 Cr | Rs. 1957.85 Cr | Rs. 1879.47 Cr | -4 % | -2.08 % |
Operating Profit | Rs. 333.75 Cr | Rs. 407.52 Cr | Rs. 620.63 Cr | + 52.29 % | + 85.96 % |
OPM % | 14.81 % | 17.23 % | 24.82 % | + 7.59 % | + 10.01 % |
Other Income | Rs. 64.7 Cr | Rs. 71.271 Cr | Rs. 106.1 Cr | + 48.87 % | + 63.99 % |
Interest | Rs. 21.42 Cr | Rs. 20.68 Cr | Rs. 21.44 Cr | + 3.68 % | + 0.09 % |
Depreciation | Rs. 58.11 Cr | Rs. 69.1 Cr | Rs. 64.35 Cr | -6.87 % | + 10.74 % |
Profit before tax | Rs. 318.92 Cr | Rs. 389.01 Cr | Rs. 640.94 Cr | + 64.76 % | + 100.97 % |
Tax % | 14.89 % | 16.46 % | 9 % | -7.46 % | -5.89 % |
Net Profit | Rs. 271.44 Cr | Rs. 324.97 Cr | Rs. 583.25 Cr | + 79.48 % | + 114.87 % |
EPS in Rs | Rs. 22.7 | Rs. 27.18 | Rs. 48.78 | + 79.47 % | + 114.89 % |
Today, we’re looking at Alkem Laboratories Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 10.96 %. However, it did see a marginal increase of 5.7 % from the previous quarter. Expenses decreased slightly by -4 % quarter-on-quarter, aligning with the annual decline of -2.08 %. Operating profit, while up 85.96 % compared to last year, faced a quarter-on-quarter increase of 52.29 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 10.01 %, but an expansion of 7.59 % sequentially. Other income rose by 48.87 % compared to the last quarter, despite an annual growth of 63.99 %. Interest expenses surged remarkably by 3.68 % from the previous quarter, yet the year-over-year increase remains at a moderate 0.09 %. Depreciation costs fell by -6.87 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 10.74 %. Profit before tax grew annually by 100.97 % but saw an increase from the preceding quarter by 64.76 %.
Tax expenses as a percentage of profits decreased slightly by -5.89 % compared to last year, with a more notable quarter-on-quarter decrease of -7.46 %. Net profit rose by 114.87 % year-on-year but experienced a 79.48 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 114.89 % but a quarterly rise of 79.47 %. In summary, Alkem Laboratories Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
---|---|---|---|---|---|
Sales | Rs. 2253.17 Cr | Rs. 2365.37 Cr | Rs. 2500.1 Cr | + 5.7 % | + 10.96 % |
Expenses | Rs. 1919.42 Cr | Rs. 1957.85 Cr | Rs. 1879.47 Cr | -4 % | -2.08 % |
Operating Profit | Rs. 333.75 Cr | Rs. 407.52 Cr | Rs. 620.63 Cr | + 52.29 % | + 85.96 % |
Net Profit | Rs. 271.44 Cr | Rs. 324.97 Cr | Rs. 583.25 Cr | + 79.48 % | + 114.87 % |
EPS in Rs | Rs. 22.7 | Rs. 27.18 | Rs. 48.78 | + 79.47 % | + 114.89 % |
In reviewing Alkem Laboratories Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 10.96 % year-on-year growth, however, there was a minor increase of 5.7 % from the previous quarter. Expenses decreased by -2.08 % compared to the previous year, with a decrease of -4 % quarter-on-quarter. Operating Profit surged by 85.96 % annually, and saw a 52.29 % increase from the last quarter.
Net Profit showed yearly increase of 114.87 %, and experienced a 79.48 % increase from the previous quarter. Earnings Per Share (EPS) rose by 114.89 % annually, however rose by 79.47 % compared to the last quarter. In essence, while Alkem Laboratories Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.